About
Basic Data Updated:
25 days agoTorrent Pharmaceuticals Ltd is a company that is involved in the production and sale of both branded and unbranded generic pharmaceutical products. A wide range of products is offered by the company in various therapeutic areas such as CV (Cardio Vascular), CNS (Central Nervous System), gastrointestinal, anti-infective, diabetology, pain management, women health, wound care, nutraceuticals, nephrology, and oncology. These products are available in the form of tablets, capsules, and parenteral. The company has three manufacturing facilities located in Indrad, Gujarat; Baddi, Himachal Pradesh and in Sikkim. These facilities have been approved by USFDA, WHO, MHRA, TGA and other global regulatory bodies. Additionally, the company has an R&D center in Ahmedabad. It is also noteworthy that TPL is a manufacturer of insulin formulations for Novo Nordisk. In order to expand its presence in the dermatological segment, TPL has acquired ZYG Pharma’s US FDA approved facility. Furthermore, the company has also acquired Elder Pharma’s branded domestic formulation business. The headquarters of TPL is located in Ahmadabad, Gujarat.
Industry
Company Details
- LocationAhmedabad, Gujarat
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L24230GJ1972PLC002126 |
| Company No. | 002126 |
| Stock Symbol | BSE : 500420 NSE : TORNTPHARM |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 15 Jul 1972 |
| Date of AGM | 07 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Ahmedabad |
Products or Services related to Torrent Pharmaceuticals Ltd
Anti Infective Agent
Herbal Sexual Health Supplement
Steroid
Quality Inspection Service
Financials of Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 11.96% increase. The company also saw a slight improvement in profitability, with a 6.05% increase in profit. The company's net worth moved up by a moderate rise of 1.74%.
Corporate Structure
Unlock access to Torrent Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Torrent Pharmaceuticals Ltd
Unlock and access historical data on people associated with Torrent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
SM
Samir Mehta
Managing DirectorAppointment Date: 01-Aug-2010
Status: Current
SM
Sudhir Menon CFOAppointment Date: 01-Sep-2018
Status: Current
CT
Chintan Trivedi Company SecretaryAppointment Date: 01-Aug-2022
Status: Current
Board Members(7)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 30 May 2023 | ₹145.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 10 May 2023 | ₹400.00 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Feb 2023 | ₹350.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Torrent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Torrent Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Ricinash Renewable Materials Private Limited
Active
27 years 3 months Manish Choksi is a mutual person
Recent activity within the organization
Charges
A charge registered on 10 May 2019 via Charge ID 100264201 with Hdfc Bank Limited was fully satisfied on 15 Sep 2023.
15 Sep 2023Annual General Meeting
Torrent Pharmaceuticals Ltd last Annual general meeting of members was held on 07 Aug 2023 as per latest MCA records.
07 Aug 2023Charges
A charge registered on 19 Mar 2021 via Charge ID 100435066 with Others was fully satisfied on 28 Jun 2023.
28 Jun 2023Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 145.00 cr with Charge ID 100728697 was registered on 30 May 2023.
30 May 2023Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 400.00 cr with Charge ID 100726423 was registered on 10 May 2023.
10 May 2023
Recent News, Updates & Announcement
Torrent Zydus in comarketing pact for liver disease drug Saroglitazar.Torrent Pharmaceuticals and Zydus Lifesciences formed a licensing and supply pact to comarket Saroglitazar Mg the sole approved treatment for NonAlcoholic Steato Hepatitis NASH and NonAlcoholic Fatty Liver Disease NAFLD in India Under the agreement Torrent gains semiexclusive rights to market as VORXAR while Zydus continues marketing as Lipaglyn and Bilypsa Licensing fees and milestone payments are part of the pact .
Economic Times 10 Nov 2023
- When Valuation Struggles Arise Navigating Friendships and Business Deals in the Pharma Industry.
When you try to buy your friends share in your business but cant agree on the price So you just chill for now and maybe try again later when the stock price goes down But your other friends might also want to join in on the deal PharmaProblems ValuationStruggle JustWaitAndSee.
Economic Times 22 Oct 2023
- Torrent Pharma mostwell placed candidate to acquire Cipla stake says report.
The New Indian Express 21 Sep 2023
- Torrent Pharma looks to tie up with CVC Capital to fund Cipla purchase.
Torrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least 1215 billion for its proposed acquisition of rival company Cipla Torrent is also engaged with Brookfield to raise 112 billion in mezzanine debt The companys founders the Sudhir and Samir Mehta family are seeking to dilute equity and create a nondisposable undertaking NDU using their shares as collateral for loans .
Economic Times 18 Sep 2023
- NCLT nixes Torrent plea over RCap resolution approval Mint.
Torrent in its plea sought the tribunals intervention to keep RCaps resolution plan in abeyance till the final order.
mint 14 Sep 2023
Frequently asked questions
What is the Incorporation or founding date of Torrent Pharmaceuticals Ltd?
